Analyst report concludes Tysabri/Avonex combo might have lead to deaths
Biogen Idec and Elan’s multiple sclerosis drug Tysabri may have killed patients because of an adverse interaction with the Biogen ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.